Composite Endpoints for Clinical Trials

A RATING SCALE FOR DEPRESSION

M. Hamilton · Journal of Neurology Neurosurgery & Psychiatry · 1960 · 32.6K citations · Full text

Social Sciences, Psychiatry, Psychology +12

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

BMJ · 1998 · 6.7K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 6K citations · Full text

Medicine, Nephrology, Pharmacology +16

Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure

Michael R. Bristow, Leslie A. Saxon, John Boehmer et al. · New England Journal of Medicine · 2004 · 5.8K citations

Medicine, Cardiology, Pharmacotherapy +14

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen et al. · The Lancet · 2002 · 5.4K citations

Medicine, Cardiology, Internal Medicine +13